Found: 30
Select item for more details and to access through your institution.
Clinical profile of dasatinib in Asian and non-Asian patients with chronic myeloid leukemia.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Successful autologous hematopoietic stem cell transplantations for severe multiple sclerosis with fludarabine and cyclophosphamide conditioning.
- Published in:
- 2006
- By:
- Publication type:
- Case Study
The establishment of a multiple myeloma clinical registry in the Asia–Pacific region: The Asia–Pacific Myeloma and Related Diseases Registry (APAC MRDR).
- Published in:
- BMC Medical Research Methodology, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12874-024-02227-0
- By:
- Publication type:
- Article
Expert consensus on the management of chronic lymphocytic leukaemia in Asia.
- Published in:
- Clinical & Experimental Medicine, 2023, v. 23, n. 6, p. 2895, doi. 10.1007/s10238-023-01007-2
- By:
- Publication type:
- Article
Treatment outcomes of T and natural‐killer/T‐cell lymphoma with ifosfamide, carboplatin and etoposide chemotherapy.
- Published in:
- Cancer Reports, 2022, v. 5, n. 9, p. 1, doi. 10.1002/cnr2.1552
- By:
- Publication type:
- Article
Newly diagnosed and previously treated multicentric Castleman disease respond equally to siltuximab.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 1, p. e28, doi. 10.1111/bjh.17177
- By:
- Publication type:
- Article
Subcutaneous bortezomib combined with weekly cyclophosphamide and dexamethasone is an efficient and well tolerated regime in newly diagnosed multiple myeloma.
- Published in:
- British Journal of Haematology, 2015, v. 169, n. 5, p. 754, doi. 10.1111/bjh.13238
- By:
- Publication type:
- Article
Recommendations for the treatment and management of adult B‐Cell acute lymphoblastic leukemia in Asia‐Pacific: Outcomes from a pilot initiative.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2024, v. 20, n. 3, p. 325, doi. 10.1111/ajco.14041
- By:
- Publication type:
- Article
Asia‐Pacific Leukemia Consortium: An innovative and collaborative initiative to improve care of leukemia and related diseases in the Asia‐Pacific region.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2023, v. 19, n. 6, p. 655, doi. 10.1111/ajco.13970
- By:
- Publication type:
- Article
WPSS is a strong prognostic indicator for clinical outcome of allogeneic transplant for myelodysplastic syndrome in Southeast Asian patients.
- Published in:
- Annals of Hematology, 2015, v. 94, n. 5, p. 761, doi. 10.1007/s00277-014-2275-x
- By:
- Publication type:
- Article
CML-413: Asciminib Provides Durable Responses and a Favorable Safety Profile in Patients with Chronic Myeloid Leukemia (CML) in Chronic Phase (CP) with the T315I Mutation in a Phase 1 Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S335, doi. 10.1016/S2152-2650(21)01784-5
- By:
- Publication type:
- Article
Combination of Asciminib+Nilotinib or Asciminib+Dasatinib in Previously Treated Chronic Myeloid Leukemia (CML) Patients: Phase 1 Study Results.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S290, doi. 10.1016/j.clml.2019.07.236
- By:
- Publication type:
- Article
Efficacy and Safety of Asciminib, a Specific Allosteric BCR-ABL1 Inhibitor Targeting the Myristoyl-Binding Site, in Patients with Chronic Myeloid Leukemia (CML) Carrying the T315I Mutation.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S289, doi. 10.1016/j.clml.2019.07.234
- By:
- Publication type:
- Article
Combination of Asciminib, a Novel and Specific BCR-ABL1 Inhibitor, Plus Imatinib in Previously Treated Chronic Myeloid Leukemia (CML) Patients: Phase 1 Study Results.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S287, doi. 10.1016/j.clml.2019.07.231
- By:
- Publication type:
- Article
Clinical Development of Asciminib (ABL001): A Randomized Phase 3 Study of Asciminib vs Bosutinib in Patients with Chronic Myeloid Leukemia (CML).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S223, doi. 10.1016/j.clml.2018.07.094
- By:
- Publication type:
- Article
Role of Surveillance Imaging in Patients With Peripheral T-Cell Lymphoma.
- Published in:
- 2016
- By:
- Publication type:
- journal article
High-dose methotrexate is effective for prevention of isolated CNS relapse in diffuse large B cell lymphoma.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 8, p. 1, doi. 10.1038/s41408-021-00535-y
- By:
- Publication type:
- Article
A phase 2 study of carfilzomib, cyclophosphamide and dexamethasone as frontline treatment for transplant-eligible MM with high-risk features (SGH-MM1).
- Published in:
- 2021
- By:
- Publication type:
- Letter
Inotuzumab ozogamicin versus standard of care in Asian patients with relapsed/refractory acute lymphoblastic leukemia.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Donor-type fresh frozen plasma is effective in preventing hemolytic reaction in major ABO incompatible allogeneic stem cell transplant.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Donor‐type fresh frozen plasma is effective in preventing hemolytic reaction in major ABO incompatible allogeneic stem cell transplant.
- Published in:
- Transfusion, 2019, v. 59, n. 1, p. 335, doi. 10.1111/trf.15053
- By:
- Publication type:
- Article
The Singapore Myeloma Study Group Consensus Guidelines for the management of patients with multiple myeloma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Thrombocytopenic Myelofibrosis (MF) Patients Previously Treated with a JAK Inhibitor in a Phase 3 Randomized Study of Momelotinib (MMB) versus Danazol (DAN) (MOMENTUM).
- Published in:
- Journal of Oncology Navigation & Survivorship, 2022, v. 13, n. 11, p. 388
- By:
- Publication type:
- Article
Phase 1/1B trial of the heat shock protein 90 inhibitor NVP-AUY922 as monotherapy or in combination with bortezomib in patients with relapsed or refractory multiple myeloma.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Dasatinib in imatinib-resistant or imatinib-intolerant chronic myeloid leukemia in blast phase after 2 years of follow-up in a phase 3 study: efficacy and tolerability of 140 milligrams once daily and 70 milligrams twice daily.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Dasatinib in imatinib-resistant or imatinib-intolerant chronic myeloid leukemia in blast phase after 2 years of follow-up in a phase 3 study.
- Published in:
- Cancer (0008543X), 2010, v. 116, n. 16, p. 3852, doi. 10.1002/cncr.25123
- By:
- Publication type:
- Article
Favorable outcomes of COVID‐19 in vaccinated hematopoietic stem cell transplant recipients: A single‐center experience.
- Published in:
- Transplant Infectious Disease, 2023, v. 25, n. 3, p. 1, doi. 10.1111/tid.14024
- By:
- Publication type:
- Article
Respiratory virus infection after allogeneic hematopoietic stem cell transplant in a tropical center: Predictive value of the immunodeficiency scoring index.
- Published in:
- Transplant Infectious Disease, 2017, v. 19, n. 3, p. n/a, doi. 10.1111/tid.12693
- By:
- Publication type:
- Article
Long-term renal outcome after allogeneic hemopoietic stem cell transplant: A comprehensive analysis of risk factors in an Asian patient population.
- Published in:
- Clinical Transplantation, 2017, v. 31, n. 4, p. n/a, doi. 10.1111/ctr.12920
- By:
- Publication type:
- Article
Variation in immunoglobulin use and impact on survival in myeloma.
- Published in:
- EJHaem, 2024, v. 5, n. 4, p. 690, doi. 10.1002/jha2.938
- By:
- Publication type:
- Article